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ABSTRACT
Epidemiological studies support the association of coffee-specific diterpenes, with various beneficial health effects. Although anti-
antiangiogenic properties of free cafestol and kahweol have been recently described, available data regarding their esterified form, in particular 
palmitate esters as the main diterpene esters present in coffee, are still rare. Given that angiogenesis plays an important role in many 
pathological conditions, including cancer growth and metastasis, this study aimed to assess and compare the potential anti-angiogenic effects 
of cafestol palmitate (CP) and kahweol palmitate (KP) in an in vitro angiogenesis model. According to our findings, both compounds inhibited 
angiogenesis steps on human microvascular endothelial cells (HMVECs), although a more significant effect was observed for KP. Compared to 
control, HMVECs viability decreased in a dose-dependent manner upon incubation either with CP or KP. Concentrations of 75 and 100 mM o f 
each compound were cytotoxic. Cell proliferation was also dramatically reduced by both diterpene esters at 50 mM, although KP had a stronger 
inhibitory effect. However, CP and KP did not induce apoptosis on HMVECs. Both compounds reduced cell migration, but this effect was only 
statistically significant after KP incubation. Inhibition of VEGFR2 expression and its downstream effector Akt, but not Erk, was also observed 
in CP- and KP-treated HMVECs. These findings were confirmed using ELISA assay for phosphorylated (active) VEGFR-2. Taken together, 
these data indicate that both CP and KP can be considered potent compounds against angiogenesis-dependent disorders. Our findings further 
indicate that KP exerts more potent anti-angiogenic effects than CP, in most of assays.
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Angiogenesis, the generation of new capillaries from pre-
existing ones, is an essential step involved in physiologic
situations, such as embryo development, tissue growth, and wound
repair [Costa et al., 2009;Wang et al., 2012]. It is a complexmultistep
process involving endothelial cell proliferation, extracellular matrix
invasion, migration, anastomosis, and ending up by the recruitment
of supporting cells [Wang et al., 2012]. On the other hand,
angiogenesis may be regarded as a detrimental process as it plays
an important role in many pathological conditions as well,
particularly in tumor proliferation, expansion, and metastasis
[Yang et al., 2006]. Providing nutrients and oxygen, as well as
removing waste products through new vasculature, is necessary for
further tumor growth [Gong et al., 2013]. The normal adult
vasculature is quiescent as endothelial cells (ECs) division occurs
approximately every 10 years [Oronsky et al., 2012]. However,
endothelial cells division in normal vessels may be induced by
angiogenic signals, which allows degradative enzymes synthesis and
release, followed by migration, proliferation, and differentiation of
ECs [Rodriguez-Nieto et al., 2002]. In fact, tumor angiogenesis
occurs due to the imbalance between stimulatory and inhibitory
factors [Rodriguez-Nieto et al., 2002; Costa et al., 2009]. Therefore,
preventing the expansion of new blood vessel networks is a way of
reducing tumor size andmetastases development [Lopes et al., 2009].
Although there is a huge list of proangiogenic factors described,
vascular endothelial growth factor (VEGF) family members are
considered surrogate markers of neovascularization. Accordingly,
VEGFs are growth factors with angiogenic activities involved in the
whole angiogenic process. They stimulate the proliferative, invasive
and migratory capacities of ECs and vascular permeability by acting
throughAkt andErk intracellular signaling pathways.Moreover, they
arewell-established ECs survival factors [Carneiro et al., 2009]. Due to
the crucial role of VEGF on angiogenesis, several molecules were
tested to develop anti-angiogenic therapy targeting these factors.
Thus, compounds targeting VEGF ligands or receptors are used
clinically in anti-angiogenic therapies [Tarallo and De Falco, 2015].
Several modulators of angiogenesis derived from natural plants
have been reported in the literatures [Rodriguez-Nieto et al., 2002;
Lopes et al., 2009; Cardenas et al., 2011]. Among several compounds
playing anti-angiogenic roles, diterpenes and diterpene esters are
currently under development due to their potential impact on human
health [Cavin et al., 2002] and their high intake through coffee
consumption, mainly Turkish and Scandinavian boiled coffee [Gross
et al., 1997]. Cafestol, kahweol, and their related esters are fat-
soluble compounds that belong to the class of diterpenes. They are
exclusively found in Arabica coffee, comprising up to 20% of coffee
lipids [Kurzrock and Speer, 2007]. These compounds are known not
only for their contribution to human health, but also for their
application to discriminate between coffee species [Schievano et al.,
2014]. Principally, diterpenes exist in coffee oil as monoesters on C17
as esterified diterpenes comprise almost 98% of total diterpenes
content. Nevertheless, in quantitative point of view, palmitate esters
are the predominant ones in Arabica coffees [Kurzrock and Speer,
2007; Erny et al., 2015], while free diterpenes occur as minor
components (less than 3.5%) [Speer and K€olling-Speer, 2006].
Several studies, either in vitro or in vivo, support the inverse
correlation between diterpenes consumption and risk of colon or
liver cancer [Huber et al., 1997; Lee et al., 2007; Cavin et al., 2008].
Protection against carcinogens such as 7,12-dimethylbenz[a]
anthracene (DMBA), 2-amino-l-methyl-6-phenylimidazo[4,5-b]-
pyridine (PhIP), and aflatoxin B1 (AFB1) have been also documented
[Lee and Jeong, 2007]. It has been also reported that cafestol and
kahweol protect against induced genotoxicity through reduction of
the expression of the activating enzymes as well as induction of the
expression of the glutathione-S-transferase (GST) as detoxifying
enzymes [Cavin et al., 1998]. Another approach is induction of phase
II detoxifying enzymes which results in inhibition of formation or
detoxification of electrophilic or oxidant metabolites. This process
interfere the initiation of tumor formation through reduction of DNA
damage [Muriel and Arauz, 2010]. Along with diterpenes and
diterpene esters, coffee contains a variety of chemicals including
caffeine and chlorogenic acids. It suggests that chemical component
in coffee may play an important role in protecting against the
occurrence and development of several disease. A study by Kim et al.
[2010] showed that chlorogenic acids, known as an antioxidant, has
anti-angiogenic effects on choroidal neovascularization. Caffeine
also has antioxidant properties along with quenching effect on the
production of hydroxyl radicals, as well as on oxidative DNA
breakage [Azam et al., 2003].
According to the literature review, moderate coffee consumption
or in another hand daily intake of2–3 cups of coffee appears to be
safe and is associatedwith neutral to beneficial effects formost of the
studied health outcomes [O0Keefe et al., 2013]. Furthermore, low or
moderate coffee consumption were contribute to less risk for hepatic
cirrhosis when compared with no coffee consumption [Liu et al.,
2015]. Nevertheless, the possibility of coffee diterpenes for an
elevation in plasma lipid profiles has been also reported which has
been indicated to substantially depend on the method of brewing.
Each extra 2mg of cafestol consumed per day producing a 1mg/dL
increase in cholesterol [Weusten-Van derWouw et al., 1994]. Several
meta analyses revealed significant positive association between
caffeinated or boiled coffee consumption and raise in serum
cholesterol [Jee et al., 2001; Cai et al., 2012]. While paper-filtered
coffee has been less frequently reported to raise serum cholesterol
[Jee et al., 2001; Cai et al., 2012; Corre^a et al., 2013]. Therefore,
during these last decades, the global view on the impact of coffee on
health has been displaced from a mostly harmful balance toward a
more beneficial profile [Cano-Marquina et al., 2013].
Although anti-carcinogenic properties of diterpenes have been
extensively studied from a pharmacological point of view [Huber
et al., 1997; Cavin et al., 2002; Cavin et al., 2003], less attention has
been paid to their anti-angiogenic properties. Previous contributions
have reported the antiangiogenic activity of free cafestol (in vitro)
[Wang et al., 2012] and free kahweol in two in vivo and one ex vivo
models of angiogenesis [Cardenas et al., 2011]. Nevertheless, as
previously mentioned, most of these compounds exist as esterified
form (98%), not free moieties.
To the best of our knowledge, the anti-angiogenic properties of
the main two diterpene esters present in coffee, namely cafestol and
kahweol palmitate (Fig. 1) have not been reported elsewhere.
Considering the lack of information about the angiogenesis
properties of diterpene esters as promising candidates for the
development of anti-angiogenic agents, we studied the ability of
these two diterpene esters to inhibit angiogenesis response of
endothelial cells.
Therefore, in the present study, we examined whether cafestol and
kahweol palmitate could inhibit angiogenesis in an in vitro model.
Cell viability, cell migration, proliferation, and apoptosis were
assessed. VEGF signaling was then evaluated, confirming the VEGF-
dependent anti-angiogenic properties of these two diterpene esters.
MATERIALS AND METHODS
CELL CULTURE
HMVECs were cultured in RPMI 1640 medium (Invitrogen Life
Technologies, Paisley, UK) supplementedwith 10%fetal bovine serum
(FBS) (Invitrogen Life Technologies), 1% penicillin/streptomycin
(Invitrogen Life Technologies, Scotland, UK), 0.1% endothelial cell
growth factor (EGF) (Sigma–Aldrich, Lisbon, Portugal), 1.176 g/L
sodiumbicarbonate (Merck,Darmstadt,Germany), 4.76 g/LHEPES (4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (Sigma–Aldrich),
0.001 g/L hydrocortisone (purity 98%—Sigma, Portugal).
Cafestol palmitate (CP) and kahweol palmitate (KP) were obtained
from LKT Laboratories (St. Paul, MN). Stock solution of each
compound (10mM) was prepared in dimethyl sulfoxide (DMSO) and
kept at 20°C. Stock solutions were diluted in 2% FBS cell culture
medium to prepare distinct treatments, as the vehicle concentration
(DMSO) never exceeded 1% (v/v) and had no significant effect on the
assays. Control procedures were performed using medium contain-
ing 2% FBS. Except for cell viability assay (MTS) which was
performed to identify the IC50. The distinct treatment at 50mM, both
for CP and KP, was used in rest of assays.
MTS TOXICITY ASSAY
Cell viability was examined using the MTS assay according to
Costa et al. [2009]. Briefly, HMVECs (1 105 cells/mL) are let to
grow to 70–90% confluence. Then, cells were incubated with
various concentrations of CP and KP (50, 75, 100mM) as
treatments and were incubated for another 24 h. Cell viability
was determined using Cell Titer 961 Aqueous ONE Solution
Reagent (MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethox-
yphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] through MTS colori-
metric assay at 492 nm according to the instructions provided by
the manufacturer. Half maximal inhibitory concentration (IC50)
values were calculated and define as concentration of the drug that
resulted in 50% inhibition in absorbance [Yang et al., 2006].
Experimental conditions were examined in triplicate. All experi-
ments were also performed in duplicates. Results are expressed as
percentage of control, which was considered to be 100%.
BrdU PROLIFERATION ASSAY
The HMVECs (1 105 cells/mL) were treated with CP or KP (50mM)
along with BrdU labeling solution (5-bromo-20-deoxyuridine) at
final concentration of 10mM and incubated for 24 h. Detection was
performed by ELISA Kit using anti-BrdU specific antibodies (Roche,
Germany), according to the manufacturer0s instructions [Machado
et al., 2015]. The absorbance of the samples was measured against a
background control (blank). Results were expressed as percentage of
control (100%). Experimental conditions were tested in triplicate
followed by duplicate repetitions of the whole experiment.
TUNEL ASSAY
HMVECs (6 104 cells/mL) were grown on glass coverslips and were
treated with CP or KP at 50mM concentration for 24 h. TUNEL
(terminal deoxynucleotidyl transferase-mediated deoxyuridine
triphosphate nick-end labeling) assay was performed as reported
previously by Carneiro et al. [2009] using the In Situ Cell Death
Detection Kit (Roche, Mannheim, Germany) according to the
manufacturer0s instructions. Glass coverslips were visualized and
photographed under a fluorescence microscope (Nikon, Tokyo,
Japan) at a magnification of 200. The percentages of TUNEL-
stained nuclei were evaluated in relation to every DAPI-stained
nuclei (40,6-diamidino-2-phenylindole, DAPI) under fluorescence
microscopy. Experimental conditions were performed in triplicate in
two independent experiments.
MIGRATION ANALYSIS
Injury assay was performed as previously described [Costa et al.,
2009]. The HMVECs (1 105 cells/mL) are let to grow until 90%
confluence. After complete adherence, a single wound was scrapped
in the center of the cell monolayers of each well. Subsequently, cells
were incubated with respective treatment of CP or KP (50mM) for
another 24 h. To measure the migration of ECs to the damaged area,
cells were photographed on a phase contrast microscope (Nikon, UK)
at a magnification of 100, immediately after wounding and after a
24 h incubation period (37°C, 5% CO2). Inhibition percentage was
expressed as percentage of the control as 100. Experimental
conditions were repeated twice and tested in duplicates.
WESTERN BLOTTING ASSAY
Western blotting assay was performed as previously described
[Machado et al., 2015]. Cells were grown to 90% confluence andwere
incubated with 50mM CP or KP. Brifely, the HMVECs lysis was
performed using RIPA buffer (Radio-Immunoprecipitation Assay)
(Chemicon International, Temecula, CA) and proteins were separated
by 8% SDS–PAGE and were transferred to Hybond nitrocellulose
membrane (Amersham, Arlington, VA). Afterward, the membrane
was incubated overnight at 4°C with primary antibodies including
Fig. 1. Structural formula of the cafestol and kahweol palmitate [Erny et al., 2015].
total VEGFR-2 (Cell Signalling, Danvers, MA), total AKT, total Erk,
and b-actin (Abcam, Cambridge, UK). The following day, the
membrane was rinsed with TBST and incubation with secondary
antibodies was accomplished at room temperature. Immunoreactive
proteins were detected using the enhanced chemiluminescence
detection system (ThermoFisher Scientific, Lisbon, Portugal).
ELISA ASSAY
The lysis of HMVECs treated with 50mM CP or KP, was performed
using RIPA buffer (Radio-Immunoprecipitation Assay) (Chemicon
International) and proteins were separated by 8% SDS–PAGE.
Subsequently, the levels of tyrosine-phosphorylated VEGFR-2
(pVEGFR-2) in HMVECs lysates weremeasured using a Duoset human
phospho-VEGFR2 (Tyr1175) ELISA kit (R&D Systems, Abingdon, UK).
The quantifications were performed in accordance to the man-
ufacturer0s instructions at 450 and 550 nm using a plate reader
(Thermo Electron Corporation, Lviv, Ukraine). Results were expressed
as percentage of control which was considered as 100%.
STATISTICAL ANALYSIS
All experiments were performed in duplicates. Quantifications are
expressed as mean standard deviation (SD) of three independent
experiments and expressed as percentage of control, which was
considered to be 100%. A one-way ANOVA analysis was performed
to evaluate differences among the groups followed by the Tukey
multiple comparisons test. Differences were considered significant
when P 0.05. All statistical analysis was performed by Minitab 16
Software (Paris, France).
RESULTS
EFFECT OF CAFESTOL AND KAHWEOL PALMITATE
ON HMVECs VIABILITY
We confirmed the HMVECs growth inhibitory effect of CP and KP
using the MTS assay. The results indicated that HMVECs viability
decreased after 24 h incubation with CP and KP in dose-dependent
manner (Fig. 2). Incubation with 50mM CP did not significantly
affect the number of viable cells relative to control whereas 75 and
100mM CP, significantly inhibited cell viability (P 0.05 vs.
control). Cell survival reduction was more pronounced after
incubation with KP as HMVECs in all treatments were significantly
less viable than those obtained for control (Fig. 2) as 75 and 100mM
treatments with KP were cytotoxic and dramatically inhibited the
viability of HMVECs (P 0.05 vs. control). Upon incubation with
100mM KP, only 5% of cells remained viable, suggesting that KP
exerted stronger inhibitory effects on HMVECs viability. In general,
around 57% and 82% cell viability in relative to control was found
upon treatment with 50mM KP or CP, respectively. These findings
prompted use a BrdU incorporation assay at 50mM of CP and KP.
CAFESTOL AND KAHWEOL PALMITATE INHIBIT
HMVECs PROLIFERATION
ECs proliferation is one of themain steps of angiogenesis [Wang et al.,
2012]. As shown in Figure 3A, both compounds revealed significant
anti-proliferative effects on HMVECs at concentration of 50mM
(Fig. 3A) asCPandKP treatments ofHMVECs for 24h, led toa decrease
in the percentage of proliferating cells when compared to control
group (P 0.05). Although KP revealed higher inhibitory effects on
proliferation of ECs, no statistical difference was found between CP
and KP (P 0.05). This result is compatible with MTS assay which
showed higher inhibitory effect of KP on HMVECs viability.
CAFESTOL AND KAHWEOL PALMITATE DO NOT INDUCE
APOPTOSIS ON HMVECs
We next examined whether 50mM CP or KP enhanced HMVECs
apoptosis by TUNEL assay. Both compounds exhibited apoptosis-
inducing activity by 24 h, as compared with control, although the
differences were not statistically significant (P 0.05). As illustrated
in Figure 3B and C, control cells revealed the lowest percentage of
apoptotic cell number (6.0%), while the percentage of apoptotic cells
upon CP incubation was less than those obtained upon KP treatment
(mean values of 6.6% and 14.4%, respectively). These latter findings
Fig. 2. Effect of CP and KP on confluent HMVECs cultures viability evaluated by MTS assay. HMVECs were seeded in 96-well plates and cultured in the presence or absence of
various concentrations of CP and KP (50, 75, and 100mM) for 24 h and viability of cells was determined by MTS assay. Incubation of cells upon treatment with CP and KP at
concentration of 50mM led to 82 7% and 57 13% cell viabilities, respectively. Results are expressed as percentage versus control as 100% viability. Depicted data are means
of values SD. Assays were repeated three times and performed in duplicates, 	P<0.05 versus control. CP, cafestol palmitate; KP, kahweol palmitate.
were compatiblewith the previous ones fromBrdUproliferation assay
(Fig. 3A). These findings suggest that CP and KP do not induce
apoptosis on HMVECs, compare to control (P 0.05).
KAHWEOL PALMITATE INHIBITS HMVECs MIGRATION
As shown in Figure 3D and E, 24 h treatment of HMVECs with CP and
KP led to a decrease in migratory capacity at the concentration of
50mM compared to control. However, this inhibitory effect was not
significant for CP (P 0.05) and cells were still able to migrate
toward the damaged area (Fig. 3D and E). This decrease was more
pronounced when HMVECs were incubated with KP (P 0.05 vs.
control). Comparison between the inhibitory effects of these two
compounds revealed the higher effect for KP. Nevertheless, no
significant difference of migration inhibition was observed between
KP and CP (P 0.05) (Fig. 3E).
CAFESTOL AND KAHWEOL PALMITATE SUPPRESS VEGFR-2
SIGNALING PATHWAY
According to our results, VEGFR-2 signaling pathway was
significantly affected (P 0.05 vs. control) in the presence of CP
andKP at the concentration of 50mM.As illustrated in Figure 4A and
B, both compounds decreased VEGFR-2 expression, being CP the one
with stronger effect. Treatment with CP and KP significantly
inhibited the expression of Akt, a downstream effector of VEGFR-2
signaling pathway compare to control group (P 0.05). However,
both compounds were unable to affect Erk expression in HMVECs
(P 0.05) (Fig. 4A and B). To confirm these findings, an ELISA assay
for phosphorylated (active) VEGFR-2 was performed. CP- and
KP-treated HMVECs at the concentration of 50mM displayed less
phosphorylated VEGFR2, compare to control (Fig. 4C), confirming
the less expression of VEGFR-2 in both treatments.
Fig. 3. Study of cell proliferation, migration, and apoptosis in HMVECs with the indicated concentration of CP and KP. (A) Cell proliferation was performed using BrdU assay at
50mM of CP and KP for 24 h. Anti-proliferative effect was found for CP or KP at the concentration of 50mM (P 0.05 vs. control). There was no significant difference between
the CP- and KP-treated groups (P 0.05). (B) Effect of CP and KP on HMVECs apoptosis assessed by TUNEL assay at 50mM of CP and KP. Fluorescent images (Magnification
200) of cells treated with CP and KP versus control after 24 h incubation with treatments at 37°C under 5% CO2. Green, apoptotic cells; Blue, Dapi-stained nuclei. (C) HMVECs
incubation with CP and KP resulted in increased apoptosis after 24 h but in non-significant manner (P 0.05 vs. control). (D) Effect of CP and KP on HMVECsmigration at 50mM
of CP and KP. These compounds inhibited HMVECs migration in injury assay after 24 h incubation at 37°C under 5% CO2, being significant in KP-treated HMVECs. (E) The
inhibitory effect on HMVECs migration was found significant (P0.05 vs. control) only when ECs incubated with KP. Graphs are the mean SD values from at least two
independent experiments, repeated three times, 	P 0.05 versus control; CP, cafestol palmitate; KP, kahweol palmitate.
DISCUSSION
Availability of ECs and to some extent awareness about the
angiogenesis process led to the development of in vitro assays to
investigate natural biological active compounds. So, the present
paper aimed to characterize and compare the effect of two bioactive
compounds present in coffee on angiogenesis in an in vitro model.
Studying the biological effects of coffee diterpenes has gained
substantial attention in the last decades. Several studies demon-
strated that coffee-specific diterpenes, cafestol and kahweol, may
diminish the incidence of certain types of cancer [Cavin et al., 2002;
Cardenas et al., 2014]. According to the literature, free cafestol and
kahweol revealed anti-angiogenic properties in vitro and ex vivo
models [Cardenas et al., 2011; Kim et al., 2012; Wang et al., 2012].
Nevertheless, free diterpenes are found in small quantities
(0.7–3.5%) in green and roasted beans [K€olling-Speer et al.,
1999] and the anti-angiogenic properties of diterpene esters which
compose up to 98% of diterpenes of coffee are not understood so far.
Therefore, in the present work, HMVECs were treated with the main
two diterpene esters namely CP and KP in a number of assays to test
the potential anti-angiogenic properties of these compounds.
Angiogenesis plays a crucial role in a wide variety of diseases,
including tumor growth andmetastasis [Kim et al., 2012;Wang et al.,
2012]. Accordingly, multi-target compounds are of clinical interest
due to their ability to prevent different steps involved in
angiogenesis [Cardenas et al., 2011]. Our results showed that CP
and KP are multitasking molecules that play a role in the regulation
of angiogenesis processes via inhibition of several steps involved in
angiogenesis, in particular the secretion of pro-angiogenic factor
VEGF in HMVECs. Furthermore, we observed stronger inhibitory
effects for KP than CP, in most assays.
We started the studyof the anti-angiogenic properties of diterpenes
by assessing the non-toxic concentration of these compounds on
HMVECs. The study of cytotoxicity byMTS assay showed that CP has
less toxicity on ECs than KP. Although cell viability decreased in
comparison to control, at 50mM CP it did not reach statistical
significance. KP revealed an enhanced toxicity compared to control.
Nevertheless, more than 50% of cells were alive after incubation for
24 h. These results indicate that upon treatment with 50mM CP and
KP, the HMVECs maintain their metabolic activity. Therefore, this
concentration was used in the following experiments. When treated
HUVECs with various concentration of pure kahweol, estimated IC50
values through MTT assay were 50 1 and 147 7mM for
proliferative and non-proliferative HUVECs, respectively [Cardenas
et al., 2011]. In another study, the IC50 value of the cafestol and
kahweol after 48h of incubationwas estimated as 82.07 and 56mM in
human mesothelioma cells (MSTO-211H), respectively [Lee et al.,
2012]. Regarding pure cafestol, treatment HUVECs up to 10mM did
not inhibited cell survival, whereas treatment with 20–80mM,
inhibited cell survival significantly, as compared with control
[Wang et al., 2012]. However, as far as the authors know, there is
no published work comparing the cytotoxic effect of diterpene esters,
namely cafestol and kahweol palmitate on HMVECs.
Concerning cell proliferation, a stronger anti-proliferative effect
of KP was observed in comparison with CP. It was clearly obvious
that both compounds considerably inhibit HMVECs proliferation
Fig. 4. Effect of cafestol and kahweol palmitate on VEGFR-2 signaling pathway. (A and B) Effect of incubation of HMVECs with CP and KP at concentrations of 50mMon total
VEGFR-2, Akt, and Erk expression was tested by Western blotting analysis. (A) Representative bands obtained after immunostaining are shown. (B) Quantification carried out
through densitometry and the relative band intensity ratio after normalization with b-actin are shown compared to control as 100%. Total VEGFR-2 expression decreased in
CP- and KP-treated cells. A significant reduction for Akt expression was also presented upon treatment with CP and KP. Erk immunostaining was not affected after incubation
with compounds analyzed (P 0.05 vs. control) (C) Phosphorylated VEGFR-2 (pVEGFR-2) in HMVECs after incubation with 50mM CP and KP was measured by ELISA assay.
Comparisons of the relative intensity of activated VEGFR-2 compare to control (as 100%) are shown. Both compounds inhibited the expression of activated VEGFR-2 in treated
ECs. 	P< 0.05 versus control. CP, cafestol palmitate; KP, kahweol palmitate.
versus the control group. The findings obtained for CP and KP are in
agreement with the results of other authors who reported inhibition
of ECs proliferation in the presence of free cafestol and kahweol
[Cardenas et al., 2011; Wang et al., 2012]. In another study, cafestol
induced anti-proliferation in Caki cells during 24 h incubation at 30
and 40M concentrations [Choi et al., 2011].
ECs, which constitute the inner layer of blood vessels, compose the
blood vessels along with perivascular cells which surround them. To
achieve new blood vessels, ECs must leave the vessel basement
membrane through secretion of several proteases. This allows
proliferative ECs to invade and migrate toward the source of the
angiogenic stimulus [Bergers and Song, 2005]. ECs migration is a
mechanically integrated molecular process that involves dynamic,
coordinate changes in cell adhesion, signal transduction, and
cytoskeletal dynamics and organization [Lamalice et al., 2007]. To
investigate whether kahweol inhibits migration of HMVECs,
migration assay was performed on CP- and KP-treated HMVECs.
We demonstrated that the number of cells migrating toward the
damaged area reduced significantly in KP-treated cells (P 0.05).
Previous study conducted by Wang et al. [2012], indicated that
HUVECs migration was significantly inhibited by 6 h treatment with
10 and 20mM cafestol. However, such a conclusion is not reached
after incubation of HMVECs by CP. According to Cardenas et al.
[2011], treatment of HUVECs with 75mM kahweol led to 30% and
60% inhibition in cell migration after 8 and 24 h of treatment,
respectively. Investigation proposed by Kim et al. [2010] showed that
in all kahweol-treated cancer cell lines with 1, 5, and 10mM pure
kahweol, the number of cells that was migrated to the lower chamber
was reduced in a concentration-dependent manner, being statisti-
cally significant for 5 and 10mM.
Although in our study, apoptosis did not play a major role in
inhibition of angiogenesis, its role in reducing this process could not
be ignored. Also, the anti-angiogenic effect of free kahweol without
apoptosis among non-tumoral cells has been previously reported as
25mM kahweol was not able to induce apoptosis in HUVECs
[Cardenas et al., 2011]. However, in another study conducted by Lee
et al. [2012], the apoptotic cell death was increased inMSTO-211H as
a result of incubation with cafestol (40 and 60mM) and kahweol (60
and 90mM) for 48 h.
Among pro-angiogenic agents, VEGF is the most potent and has a
critical role in angiogenesis and can be accounted as the promoter
for ECs growth, migration, and invasion [Costa et al., 2009]. VEGFR-
2, which is expressed in most adult vascular ECs upon angiogenic
stimuli, is considered the main transducer of VEGFA effects on
endothelial cell differentiation, proliferation, migration, and
formation of the vascular tube [Tugues et al., 2011]. VEGFR-2
undergoes autophosphorylation and the activated form (pVEGFR-2)
triggering signaling pathways which is critical for pathological
angiogenesis [Machado et al., 2015]. Accordingly, anti-angiogenic
therapy is searching for molecules able to target VEGF ligands or
receptors [Tarallo and De Falco, 2015]. We verified that CP and KP
strongly suppressed the total VEGFR-2 and Akt expression
compared to control. In contrast, exposure of HMVECs to CP and
KP has no effects on total Erk expression during 24 h incubation. Our
findings were corroborated by another study [Wang et al., 2012],
which reported that Erk phosphorylation was not affected by free
cafestol in HUVECs. Besides that, due to the crucial role of VEGF
signaling pathway through the VEGFR-2 tyrosine kinase phosphor-
ylation, inhibition of this pathway could be an effective approach
against angiogenesis. Therefore, the presence of less activated
VEGFR-2 (pVEGFR-2) in CP- and KP-treated HMVECs, suggests
these compounds as VEGFR-2 inhibitors. The inhibitory effect of free
cafestol on phosphorylation of VEGFR-2 in HUVECs at concentra-
tion of 20mM was previously reported [Wang et al., 2012]. They
concluded that free cafestol mainly influences signaling pathways
downstream of VEGF subsequently leading to anti-angiogenesis
[Wang et al., 2012]. Kim et al. [2012] reported that free kahweol
inhibited VEGF secretion and VEGF promoter activity in treated
human cancer cells. However, no inhibitory effect was observed on
normal human epithelial cells. They suggested that kahweol
mediates VEGF expression at the transcriptional level [Kim et al.,
2012]. Kim et al. [2012] reported that the inhibitory effect of kahweol
on cancer metastasis may contribute to inhibition of the expression
and secretion of some MMPs (matrix metalloproteinases), inhibition
of activity of STAT3 (signal transducer and activator of transcrip-
tion), as well as inhibition of secretion of pro-angiogenic factor
VEGF by cancer cells. However, such a report does not exist for
cafestol. Therefore, kahweol may be a potential candidate for both
preventive and therapeutic strategies [Kim et al., 2012].
In general, more recent reports have provided new insights into
anti-angiogenic effects of kahweol and cafestol; however, the anti-
angiogenic activities of CP and KP remain unclear. Investigation on
pure cafestol showed that this compound could induce apoptosis in
renal carcinoma Caki cells via reduction of mitochondrial membrane
potential (MMP), activation of caspase 3, cytochrome c release, and
down-regulation of anti-apoptotic proteins (Bcl-2, Bcl-xL, Mcl-1,
and cFLIP) [Choi et al., 2011]. Likewise, Wang et al. [2012] concluded
that cafestol inhibits angiogenesis of HUVECs via inhibition of
proliferation, migration, and tube formation through several
pathways including inhibition of phosphorylation of FAK and Akt
and by a decrease in nitric oxide production. Similarly, kahweol
exerted anti-angiogenic properties with inhibitory effects on ECs
proliferation, migration, invasion, and tube formation on Matrigel
[Wang et al., 2012]. The potential role of kahweol on remodeling of
extracellular matrix by targeting MMP-2 and uPA has also been
proved [Cardenas et al., 2011]. Inhibition of metastasis by kahweol
through the modulating expressions of MMPs and VEGF via STAT3
inactivation was also reported previously [Kim et al., 2012]. The
higher reactivity of kahweol rather than cafestol may be attributed to
the presence of one extra conjugated double bound in furan ring.
Presence of this extra double bond increases the susceptibility of
furan rings to electrophilic attack and subsequently oxidation [de
Lucia et al., 2009]. Therefore, kahweol may be a more potent
inhibitor of other molecules oxidation than cafestol. However,
palmitate ester of cafestol (CP) had greater inhibitory effect on
VEGFR expression than palmitate ester of kahweol (KP). This
observation may suggest that chemical modification of cafestol to
esterified form could improve its biological activities in some cases.
According to Guo et al. [2008], incubation of endothelial progenitor
cells (EPCs) with palmitic acid at concentrations of 0.2mM or higher
inhibited EPCs proliferation, migration, and tube formation in a
dose-dependent manner via downregulation of Akt/eNOS signal
pathway. In another more recent study, Jiang et al. [2010] have
demonstrated that palmitic acid could increase EPCs apoptosis in a
dose- and time-dependent manner via p38 and JNK MAPKs
pathways; however, Erk expressionwas not affected under treatment
with palmitic acid. Since palmitic acid also has anti-angiogenic
properties, esterification of cafestol and kahweol with palmitic acid
tend to improve their properties. Therefore, probably different
obtained results between CP and KP could be attributed to the
presence of fatty acid in their molecular structures whichmay induce
synergetic effects in some assays.
In conclusion, this study provides new insights into the anti-
angiogenic properties of the main diterpene esters. This results
support the potential application of these two biological active
compounds against angiogenesis-dependent disorders. The present
study demonstrated that CP and KP, as the main diterpene esters
present in Arabica coffee are able to prevent several steps involved in
angiogenesis. Prevention of VEGF release to HMVECs culture
medium through suppression of Akt signaling pathway as well as
their inhibitory effects on phosphorylated (active) VEGFR-2 was
clearly indicated. Natural VEGFR-2 expression inhibitors such as CP
and KP combined with other therapies may improve the efficiency
and quality of cancer treatment or anti-angiogenic therapies. Our
findings further indicate that in most cases, KP exerts more potent
anti-angiogenic effects than CP. Although further studies, in
particular, in vivo models are required to support these findings.
Research targeting the action of these compounds on different types
of cells is required, as well.
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